A proposed guideline for psoralen photochemotherapy (PUVA) with atopic dermatitis: successful therapeutic effect on severe and intractable cases.

[1]  T. Yoshiike,et al.  Topical Psoralen Photochemotherapy for Atopic Dermatitis: Evaluation of Two Therapeutic Regimens for Inpatients and Outpatients , 1991, The Journal of dermatology.

[2]  H. Hönigsmann,et al.  Phototherapy and photochemotherapy. , 1990, Seminars in dermatology.

[3]  K. Keczkes,et al.  Cutaneous and ocular side‐effects of PUVA photochemotherapy‐a 10‐year follow‐up study , 1989, Clinical and experimental dermatology.

[4]  H. Roenigk,et al.  Long-term follow-up of skin cancer in the PUVA-48 cooperative study. , 1989, Archives of dermatology.

[5]  R. Morris.  Skin tumors in the European PUVA study. Eight-year follow-up of 1643 patients treated with PUVA for psoriasis. , 1989, Journal of the American Academy of Dermatology.

[6]  J. Hawk,et al.  The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents , 1988, The British journal of dermatology.

[7]  H. Tagami,et al.  Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow-up study. , 1988, Journal of the American Academy of Dermatology.

[8]  S. Lerman,et al.  Psoralen--long-wave ultraviolet therapy and human cataractogenesis. , 1982, Investigative ophthalmology & visual science.

[9]  R. Stern,et al.  Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. , 1979, The New England journal of medicine.

[10]  J. Parrish,et al.  Oral psoralen photochemotherapy of atopic eczema , 1978, The British journal of dermatology.

[11]  H. Hönigsmann,et al.  Skin tumors in the European PUVA Study , 1987 .

[12]  J. Ortonne,et al.  La photochimiothérapie orale de l’eczéma atopique , 1979 .